Course Description

Background

An FDE Emergency Use Authorization (EUA) has been approved for administration of the Pfizer “Pediatric Formulation” to children ages 5-11.  This 45 minute training will review key clinical considerations for the COVID-19 vaccine and minors, determining eligibility and obtaining consent, and pediatric vaccination administration.

Objectives

1. Review CDC and FDA recommendations for the Pfizer BioNTech COVID-19 vaccine for children 5-11 years old

2. Summarize workflow of offering the Pfizer vaccine to children at the state-operated Mass Vaccination Sites

3. Provide a demonstration of pediatric vaccination technique

4. Explore options for managing typical childhood fears of receiving vaccines

Target Audience

Any staff member working at a state-operated Mass Vaccination Site offering pediatric vaccination.